More evidence on the limited impact of state oral oncology parity laws.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30566761.
- Also identified by DOI 10.1002/cncr.31904 and PMC identifier 6361375.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Most states have enacted legislation cancer parity laws in order to ensure that copayments are similar for cancer drugs whether the drug is administered orally or intravenously. However, the parity laws have had a limited impact, often only lower copayment for those that already had low copayments.
Medical subject headings
- Breast Neoplasms